CGRP receptor drugs for Migraine

5 tracked CGRP receptor drugs in the Migraine race. The class explanation lives on the CGRP receptor page; the full indication pipeline across every mechanism is on the Migraine page.

5 approved / phase 4

Head-to-head evidence: Atogepant (Qulipta) vs Erenumab (Aimovig) · Atogepant (Qulipta) vs Rimegepant (Nurtec ODT) · Atogepant (Qulipta) vs Ubrogepant (Ubrelvy) · Atogepant (Qulipta) vs Zavegepant (Zavzpret) · Erenumab (Aimovig) vs Rimegepant (Nurtec ODT) · Erenumab (Aimovig) vs Ubrogepant (Ubrelvy)

The roster

← all CGRP receptor drugs